(1)
Blauvelt, A.; Fowler, Jr., J. F.; Schuck, E.; Jauch, J.; Woehling, H.; Leonardi, C. L. A Randomized, Double-Blind, Multicenter Study to Compare the Efficacy, Safety, and Immunogenicity of a Proposed Adalimumab Biosimilar (GP2017) With Originator Adalimumab in Patients With Moderate-to-Severe Chronic Plaque Psoriasis. J of Skin 2017, 1, s29.